Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Gedeon Richter Sees Profit Jump By 40%
Driven By Strong Vraylar Tailwind As Cariprazine Brand Beats Expectations
Feb 21 2020
•
By
Penelope MacRae
Gedeon Richter has seen its net profit leap by 40% • Source: Shutterstock
More from Earnings
More from Business